<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title> Analysis of Adverse Event</title>

<script src="site_libs/header-attrs-2.29/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/cerulean.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.13.2/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<script src="site_libs/navigation-1.1/codefolding.js"></script>
<link href="site_libs/highlightjs-9.12.0/textmate.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<link href="site_libs/pagedtable-1.1/css/pagedtable.css" rel="stylesheet" />
<script src="site_libs/pagedtable-1.1/js/pagedtable.js"></script>
<link href="site_libs/tabwid-1.1.3/tabwid.css" rel="stylesheet" />
<script src="site_libs/tabwid-1.1.3/tabwid.js"></script>
<script src="site_libs/kePrint-0.0.1/kePrint.js"></script>
<link href="site_libs/lightable-0.0.1/lightable.css" rel="stylesheet" />
<link href="site_libs/htmltools-fill-0.5.8.1/fill.css" rel="stylesheet" />
<script src="site_libs/htmlwidgets-1.6.4/htmlwidgets.js"></script>
<script src="site_libs/plotly-binding-4.10.4/plotly.js"></script>
<script src="site_libs/typedarray-0.1/typedarray.min.js"></script>
<link href="site_libs/crosstalk-1.2.1/css/crosstalk.min.css" rel="stylesheet" />
<script src="site_libs/crosstalk-1.2.1/js/crosstalk.min.js"></script>
<link href="site_libs/plotly-htmlwidgets-css-2.11.1/plotly-htmlwidgets.css" rel="stylesheet" />
<script src="site_libs/plotly-main-2.11.1/plotly-latest.min.js"></script>
<link href="site_libs/font-awesome-6.5.2/css/all.min.css" rel="stylesheet" />
<link href="site_libs/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>









<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->
<style type="text/css">
.code-folding-btn { margin-bottom: 4px; }
</style>



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Zehui Bai</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="index.html">
    <span class="fa fa-home"></span>
     
    Home
  </a>
</li>
<li>
  <a href="02-Clinical_Experience.html">
    <span class="fa fa-user"></span>
     
    Clinical Experience
  </a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-sliders"></span>
     
    Sample Size
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="03-SSC-Everything-to-Know-About-Sample-Size-Determination.html">Everything to Know About Sample Size Determination</a>
    </li>
    <li>
      <a href="03-SSC-Choosing-the-Effect-Size-for-Sample-Size-Calculations.html">Choosing the Effect Size</a>
    </li>
    <li>
      <a href="03-SSC-Biosimilar-Trials.html">Statistical Considerations for the Design and Analysis of Biosimilar Trials</a>
    </li>
    <li>
      <a href="03-SSC-Sample-Size-and-Power-for-Non-Parametric-Analysis.html">Sample Size and Power for Non-Parametric Analysis</a>
    </li>
    <li>
      <a href="03-SSC-Power-for-Complex-Hypotheses.html">Power for Complex Hypotheses</a>
    </li>
    <li>
      <a href="03-SSC-Alternatives-to-Power.html">Bayesian methods - Alternatives to Power</a>
    </li>
    <li>
      <a href="03-SSC-Sample-Size-for-Pilot-Studies.html">Sample Size for Pilot Studies</a>
    </li>
    <li>
      <a href="03-SSC-Case-Continuous-Endpoint.html">Sample Size Determination for Continuous Endpoint</a>
    </li>
    <li>
      <a href="03-SSC-Case-Categorical-Endpoint.html">Sample Size Determination for Categorical Endpoint</a>
    </li>
    <li>
      <a href="03-SSC-Sample-Size-Determination-for-Counts-and-Rates.html">Sample Size Determination for Counts and Rates</a>
    </li>
    <li>
      <a href="03-SSC-Case-Survival-Endpoint.html">Sample Size Determination for Survival Endpoint</a>
    </li>
    <li>
      <a href="03-SSC-Case-Repeated-Measures.html">Sample Size Determination for Repeated Measures</a>
    </li>
    <li>
      <a href="03-SSC-IA-Sequential-Design.html">Statistical Considerations for Group Sequential Design</a>
    </li>
    <li>
      <a href="03-SSC-IA-Adaptive-Design.html">Statistical Considerations for Adaptive Design</a>
    </li>
    <li>
      <a href="03-SSC-Multiple-Test.html">Sample Size for Multiple Test</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-pencil-square-o"></span>
     
    Study Design
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="04-Design-Estimands-Framework.html">Estimands Framework</a>
    </li>
    <li>
      <a href="04-Design-Estimands-Practice.html">Estimands and Sensitivity Analyses</a>
    </li>
    <li>
      <a href="04-Design-Phase-I-Trials---Design-Considerations.html">Phase I Trials - Design Considerations</a>
    </li>
    <li>
      <a href="04-Design-Phase-II-Trials---Design-Considerations.html">Phase II Trials - Design Considerations</a>
    </li>
    <li>
      <a href="04-Design-Phase-III-Trials---Design-Considerations.html">Phase III Trials - Design Considerations</a>
    </li>
    <li>
      <a href="04-Design-Phase-IV-Trials---Design-Considerations.html">Phase IV Trials - Design Considerations for Post Marketing Surveillance</a>
    </li>
    <li>
      <a href="04-Design-Complex-Sequential-Trials.html">Complex Sequential Analysis Trials</a>
    </li>
    <li>
      <a href="04-Design-Adaptive-Clinical-Trials.html">Adaptive Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Bayesian-Clinical-Trials.html">Bayesian Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Dose-Escalation-and-Stratification-Designs.html">Dose Escalation and Stratification Designs in Early Oncology Development</a>
    </li>
    <li>
      <a href="04-Design-Single-Arm-Clinical-Trials.html">Single Arm Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Diagnostic-Study-Design-and-Evaluation.html">Diagnostic Study-Design and Evaluation</a>
    </li>
    <li>
      <a href="04-Design-Diagnostic-Study-MRMC.html">Diagnostic Study-Multireader Multicase (MRMC)</a>
    </li>
    <li>
      <a href="04-Design-Vaccine-Design.html">Vaccine Trials</a>
    </li>
    <li>
      <a href="04-Design-Hierarchical-composite-endpoints.html">Hierarchical Composite Endpoints</a>
    </li>
    <li>
      <a href="04-Design-Externally-Controlled-Trials.html">Considerations for the Design and Conduct of Externally Controlled Trials</a>
    </li>
    <li>
      <a href="04-Design-Noninferiority-Trials.html">Noninferiority Trials</a>
    </li>
    <li>
      <a href="04-Design-Bioequivalence-and-Biosimilar-Trials.html">Bioequivalence and Biosimilar Trials</a>
    </li>
    <li>
      <a href="04-Design-Exploring-Survival-Analysis-Designs-for-Clinical-Trials.html">Exploring Survival Analysis Designs for Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Projecting-How-Long-Your-Trial-Will-Take.html">Projecting How Long Your Trial Will Take</a>
    </li>
    <li>
      <a href="04-Design-Regulatory-Submission.html">Regulatory Submission from Stats Perspective</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-line-chart"></span>
     
    Data Visualization
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="05-Plot-Time-To-Event.html">Time to Event Data Visualization</a>
    </li>
    <li>
      <a href="05-Plot-PRO-Data.html">Patient Reported Outcome Data Visualization</a>
    </li>
    <li>
      <a href="05-Plot-SSC-and-Power-Calculation.html">Sample Size and Power Calculations Visualization</a>
    </li>
    <li>
      <a href="05-Plot-Correlation.html">Correlation Visualization</a>
    </li>
    <li>
      <a href="05-Plot-Model-Table.html">Clinical Data and Model visualization</a>
    </li>
    <li>
      <a href="05-Plot-ScatterPlot.html">Scatter and Line Plot</a>
    </li>
    <li>
      <a href="05-Plot-BarPlot.html">Bar Chart</a>
    </li>
    <li>
      <a href="05-Plot-PieChart.html">Pie Chart</a>
    </li>
    <li>
      <a href="05-Plot-BoxPlot.html">Box Plot</a>
    </li>
    <li>
      <a href="05-Plot-Histogram.html">Histogram</a>
    </li>
    <li>
      <a href="05-Plot-Forest-Plot.html">Forest Plot</a>
    </li>
    <li>
      <a href="05-Plot-Flow-Chart.html">Flow Chart</a>
    </li>
    <li>
      <a href="05-Plot-Some-Interesting.html">Some Interesting Plots</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-calculator"></span>
     
    Statistical Analysis
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="06-Analysis-Linear-Regression.html">Linear Regression</a>
    </li>
    <li>
      <a href="06-Analysis-Logistic-Regression.html">Logistic Regression</a>
    </li>
    <li>
      <a href="06-Analysis-Mixed-Model.html">Mixed Model</a>
    </li>
    <li>
      <a href="06-Analysis-MMRM.html">Mixed Model Repeated Measures</a>
    </li>
    <li>
      <a href="06-Analysis-GEE.html">Generalized Estimating Equation</a>
    </li>
    <li>
      <a href="06-Analysis-ANOVA.html">Analysis of Variance</a>
    </li>
    <li>
      <a href="06-Analysis-Survival-Analysis.html">Survival Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-Survival-Competing-Risk.html">Survival Analysis - Competing Risk</a>
    </li>
    <li>
      <a href="06-Analysis-Missing-Data.html">Missing Data Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-MI-Implementation.html">Multiple Imputation Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-SSD.html">Safety Signal Detection and Evaluation</a>
    </li>
    <li>
      <a href="06-Analysis-Meta-Analysis.html">Meta Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-PK-and-PD.html">PK and PD Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-Time-Series-Analysis.html">Time Series Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-SEM.html">Structural Equation Modeling</a>
    </li>
    <li>
      <a href="06-Analysis-Factor-Analysis.html">Factor Analysis</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-bar-chart"></span>
     
    Machine Learning
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="07-ML-Bayesian-Theory.html">Bayesian Theory</a>
    </li>
    <li>
      <a href="07-ML-Bayesian-Analysis.html">Bayesian Analysis</a>
    </li>
    <li>
      <a href="07-ML-Regularization-Penalized-Regression.html">Regularization Penalized Regression</a>
    </li>
    <li>
      <a href="07-ML-Loss-Regression.html">Loss Functions in Machine Learning</a>
    </li>
    <li>
      <a href="07-ML-PCA.html">Principal Component Analysis</a>
    </li>
    <li>
      <a href="07-ML-KNN.html">K-Nearest Neighbors</a>
    </li>
    <li>
      <a href="07-ML-SVM.html">Support Vector Machine</a>
    </li>
    <li>
      <a href="07-ML-Tree-Models.html">Tree Models</a>
    </li>
    <li>
      <a href="07-ML-LDA.html">Linear Discriminant Analysis</a>
    </li>
    <li>
      <a href="07-ML-Cluster-Analysis.html">Cluster Analysis</a>
    </li>
    <li>
      <a href="07-ML-Neural-Networks.html">Neural Network</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-stethoscope"></span>
     
    Clinical Analysis (ADaM)
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="08-Clinical-Disposition-Baseline.html">Disposition and Baseline</a>
    </li>
    <li>
      <a href="08-Clinical-Efficacy-Continuous.html">Efficacy Continuous Analysis</a>
    </li>
    <li>
      <a href="08-Clinical-Efficacy-Responder.html">Efficacy Responder Analysis</a>
    </li>
    <li>
      <a href="08-Clinical-Survival-Analysis.html">Survival Analysis</a>
    </li>
    <li>
      <a href="08-Clinical-Pharmacokinetics-Analysis.html">Pharmacokinetics Analysis</a>
    </li>
    <li>
      <a href="08-Clinical-Adverse-Event.html">Adverse Event Visualization</a>
    </li>
    <li>
      <a href="08-Clinical-Laboratory-Data.html">Laboratory Data Visualization</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="08-CV.html">
    <span class="fa fa-file-pdf-o"></span>
     
    CV
  </a>
</li>
<li>
  <a href="mailto:zehuibai@outlook.com">
    <span class="fa fa-envelope-o"></span>
     
    Contact me
  </a>
</li>
<li>
  <a href="https://github.com/Zehuibai">
    <span class="fa fa-github"></span>
     
    GitHub
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">

<div class="btn-group pull-right float-right">
<button type="button" class="btn btn-default btn-xs btn-secondary btn-sm dropdown-toggle" data-toggle="dropdown" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false"><span>Code</span> <span class="caret"></span></button>
<ul class="dropdown-menu dropdown-menu-right" style="min-width: 50px;">
<li><a id="rmd-show-all-code" href="#">Show All Code</a></li>
<li><a id="rmd-hide-all-code" href="#">Hide All Code</a></li>
</ul>
</div>



<h1 class="title toc-ignore"><p><img src="logo.png"
style="width:3in" /><br />
Analysis of Adverse Event</p></h1>

</div>


<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>Efficacy and safety are two crucial aspects of assessing the
risk-benefit ratio of a drug. When a drug’s efficacy meets the
regulatory requirements, its safety profile must also be within a
reasonable range. However, clinical trials sometimes reveal peculiar
adverse reactions that attract regulatory attention, such as
immune-related adverse events (irAEs) from PD-1/L1 inhibitors, bone
damage from BTK inhibitors, and bleeding events from EGFR inhibitors. In
such cases, sponsors are often required to conduct more in-depth
analyses to clarify the drug’s safety. Based on past clinical trial
experiences and literature, here have summarized some analytical methods
for adverse events that sponsors and regulatory bodies might require for
your reference.</p>
<div id="incidence" class="section level2">
<h2>Incidence</h2>
<p>Calculating the incidence rate is a fundamental requirement for AE
analysis. This includes overall incidence rates, incidence by preferred
terms (PT), standard of care (SOC), and by severity levels, including
AEs that lead to drug discontinuation, interruption of treatment, or
death.</p>
</div>
<div id="time-to-occurrence-and-duration" class="section level2">
<h2>Time to Occurrence and Duration</h2>
<p>The time from drug administration to the occurrence of an AE and the
duration of the AE are two important dimensions of AE analysis. If an AE
persists, it indicates that this type of AE tends to last long
clinically and may require the sponsor to explain how to manage and
ensure safety, especially for AEs of grade 3 or higher, which are of
greater concern. The following table displays a common summary
format:</p>
<p><img src="./02_Plots/Visualization/AEs/AE_Time2Onset.png" />
<em>Source: John Shaik et al., PharmaSUG 2016.</em></p>
<p>The figure below demonstrates the use of Kaplan-Meier (KM) curves to
analyze the occurrence of AEs.</p>
<p><img src="./02_Plots/Visualization/AEs/AE_KMPlot.png" /> <em>Source:
Kriss Harris et al., PhUSE 2017</em></p>
</div>
<div id="temporal-distribution-of-aes" class="section level2">
<h2>Temporal Distribution of AEs</h2>
<p>Analyzing the patterns of AE occurrence over different time periods.
For example, although an AE may occur rapidly, it might disappear
quickly or be transient, thus having a minimal impact. If a certain type
of AE continues throughout the medication period and is of a higher
CTCAE grade, it is likely drug-related and clinical considerations for
management are necessary.</p>
<p>The following figure shows the distribution over time of three types
of AEs in melanoma patients treated with Nivo+Ipi. It can be observed
that most skin-related AEs cease to appear after 3 months, and GI and
liver-related AEs significantly decrease after 6 months.</p>
<p><img
src="./02_Plots/Visualization/AEs/AE_Temporal%20Distribution.png" /></p>
</div>
<div id="outcome-summary-of-adverse-events-aes" class="section level2">
<h2>Outcome Summary of Adverse Events (AEs)</h2>
<p>The outcome of an AE represents whether interventions against the AE
are effective. If there is no recovery, the duration of the AE will be
prolonged, indicating that effective intervention for this type of AE is
challenging.</p>
</div>
<div id="analysis-of-factors-influencing-aes" class="section level2">
<h2>Analysis of Factors Influencing AEs</h2>
<p>If the AEs in the experimental group are particularly prominent
(e.g., significantly more bleeding events or a higher mortality rate in
the experimental group compared to controls), regulatory bodies often
require an analysis of influencing factors. If clinical influencing
factors can be identified, measures can be taken to control them, also
indicating that the AEs are predictable.</p>
<p>Sometimes, to reduce the bias due to timing in between-group
comparisons, a landmark analysis strategy might be used, which excludes
patients who stopped treatment or died prematurely. For example,
patients who terminated treatment or died within two months may be
excluded.</p>
</div>
<div id="hazard-ratio-hr-of-ae-occurrence" class="section level2">
<h2>Hazard Ratio (HR) of AE Occurrence</h2>
<p>This is also a method for analyzing differences in AE characteristics
between two groups, using survival analysis to study the hazard ratio of
AE occurrence. The figure below shows the risk of irAEs in the
Keynote-054 study comparing Drug K with a placebo (HR = 5.0), indicating
that the risk of irAEs is significantly higher in the experimental
group.</p>
<p><img src="./02_Plots/Visualization/AEs/AE_HR.png" /></p>
</div>
</div>
<div id="ae-descriptive-analysis" class="section level1">
<h1>AE Descriptive Analysis</h1>
<div id="treatment-emergent-summary-table" class="section level2">
<h2>Treatment-emergent summary table</h2>
<pre class="r"><code>dataADSL &lt;- subset(dataAll$ADSL, SAFFL == &quot;Y&quot;) 

# Filter ADAE for safety and treatment-emergent flags
dataTEAE &lt;- dataAll$ADAE %&gt;%
  filter(SAFFL == &quot;Y&quot;, TRTEMFL == &quot;Y&quot;) %&gt;%
  mutate(
    TRTA = fct_reorder(TRTA, TRTAN)  # reorder treatment
  )

# Total AE population (only safety flag, not TRTEMFL)
dataTotalAE &lt;- dataAll$ADSL %&gt;%
  filter(SAFFL == &quot;Y&quot;) %&gt;%
  mutate(
    TRTA = fct_reorder(TRT01A, TRT01AN)
  )

# TEAE with worst-case scenario by AE severity
dataTEAE &lt;- dataTEAE %&gt;%
  mutate(
    AESEV = factor(AESEV, levels = c(&quot;MILD&quot;, &quot;MODERATE&quot;, &quot;SEVERE&quot;)),
    AESEVN = as.numeric(AESEV)
  ) %&gt;%
  group_by(USUBJID, TRTA) %&gt;%
  mutate(
    WORSTINT = if_else(AESEVN == max(AESEVN, na.rm = TRUE), as.character(AESEV), NA_character_)
  ) %&gt;%
  ungroup() %&gt;%
  mutate(
    WORSTINT = factor(WORSTINT, levels = levels(AESEV))
  )



## specify labels for each variable:
varsAE &lt;- c(&quot;TRTEMFL&quot;, &quot;AESER&quot;, &quot;AESDTH&quot;, &quot;AEREL&quot;)

dataTotalAE &lt;- dataAll$ADSL %&gt;%
  filter(SAFFL == &quot;Y&quot;) %&gt;%
  mutate(TRTA = fct_reorder(TRT01A, TRT01AN))

getSummaryStatisticsTable(
  data = dataTEAE,
  colVar = &quot;TRTA&quot;,
  var = c(&quot;TRTEMFL&quot;, &quot;AESER&quot;, &quot;WORSTINT&quot;, &quot;AESDTH&quot;, &quot;AEREL&quot;), 
  varFlag = c(&quot;TRTEMFL&quot;, &quot;AESER&quot;, &quot;AESDTH&quot;),
  varLab = c(TRTEMFL = &quot;Treatment-Emergent&quot;, WORSTINT = &quot;Worst-case severity:&quot;),
  varGeneralLab = &quot;Subjects with, n(%):&quot;,
  varInclude0 = TRUE,
  varTotalInclude = &quot;WORSTINT&quot;,
  stats = getStats(&#39;n (%)&#39;),
  emptyValue = &quot;0&quot;,
  labelVars = labelVars,
  dataTotal = dataTotalAE,  # &lt;- Use ADSL-based population for N and percentages
  title = tools::toTitleCase(&quot;Table: Summary Table of Treatment-emergent Adverse Events (Safety Analysis Set)&quot;)
  # file = file.path(&quot;tables_CSR&quot;, &quot;Table_TEAE_summary.docx&quot;)  # optional export
)</code></pre>
<div class="tabwid"><style>.cl-db35ca12{}.cl-db2f64ec{font-family:'Times';font-size:8pt;font-weight:bold;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-db2f6500{font-family:'Times';font-size:8pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-db31f43c{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db31f446{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db31f450{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db31f451{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db31f452{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db31f45a{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db320fe4{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db320fee{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db320fef{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db320ff8{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db320ff9{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db321002{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db321003{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db32100c{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db32100d{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db321016{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db321017{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db321020{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db32102a{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db32102b{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}</style><table data-quarto-disable-processing='true' class='cl-db35ca12'><thead><tr style="overflow-wrap:break-word;"><th  colspan="4"class="cl-db320fe4"><p class="cl-db31f43c"><span class="cl-db2f64ec">Table: Summary Table of Treatment-Emergent Adverse Events (Safety Analysis Set)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-db320fef"><p class="cl-db31f43c"><span class="cl-db2f64ec">Subjects with, n(%):</span></p></th><th  rowspan="2"class="cl-db320ff8"><p class="cl-db31f446"><span class="cl-db2f64ec">Placebo</span><br><span class="cl-db2f64ec">(N=2)</span></p></th><th  rowspan="2"class="cl-db320ff8"><p class="cl-db31f446"><span class="cl-db2f64ec">Xanomeline Low Dose</span><br><span class="cl-db2f64ec">(N=2)</span></p></th><th  rowspan="2"class="cl-db320ff8"><p class="cl-db31f446"><span class="cl-db2f64ec">Xanomeline High Dose</span><br><span class="cl-db2f64ec">(N=3)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-db320ff9"><p class="cl-db31f450"><span class="cl-db2f64ec">Variable group</span></p></th></tr></thead><tbody><tr style="overflow-wrap:break-word;"><td class="cl-db321003"><p class="cl-db31f451"><span class="cl-db2f6500">Treatment-Emergent</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">2 (100)</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">2 (100)</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db32100d"><p class="cl-db31f451"><span class="cl-db2f6500">Serious Event</span></p></td><td class="cl-db321016"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db321016"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db321016"><p class="cl-db31f452"><span class="cl-db2f6500">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db321017"><p class="cl-db31f451"><span class="cl-db2f6500">Worst-case severity:</span></p></td><td class="cl-db321020"><p class="cl-db31f452"><span class="cl-db2f6500">2 (100)</span></p></td><td class="cl-db321020"><p class="cl-db31f452"><span class="cl-db2f6500">2 (100)</span></p></td><td class="cl-db321020"><p class="cl-db31f452"><span class="cl-db2f6500">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db32102a"><p class="cl-db31f45a"><span class="cl-db2f6500">MILD</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db32102a"><p class="cl-db31f45a"><span class="cl-db2f6500">MODERATE</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">1 (50.0)</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db321003"><p class="cl-db31f45a"><span class="cl-db2f6500">SEVERE</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">2 (100)</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">1 (50.0)</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db32100d"><p class="cl-db31f451"><span class="cl-db2f6500">Results in Death</span></p></td><td class="cl-db321016"><p class="cl-db31f452"><span class="cl-db2f6500">2 (100)</span></p></td><td class="cl-db321016"><p class="cl-db31f452"><span class="cl-db2f6500">1 (50.0)</span></p></td><td class="cl-db321016"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db321017"><p class="cl-db31f451"><span class="cl-db2f6500">Causality</span></p></td><td class="cl-db321020"><p class="cl-db31f452"><span class="cl-db2f6500"></span></p></td><td class="cl-db321020"><p class="cl-db31f452"><span class="cl-db2f6500"></span></p></td><td class="cl-db321020"><p class="cl-db31f452"><span class="cl-db2f6500"></span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db32102a"><p class="cl-db31f45a"><span class="cl-db2f6500">NONE</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">1 (50.0)</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">2 (100)</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db32102a"><p class="cl-db31f45a"><span class="cl-db2f6500">POSSIBLE</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">1 (50.0)</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">1 (50.0)</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db32102a"><p class="cl-db31f45a"><span class="cl-db2f6500">PROBABLE</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">1 (50.0)</span></p></td><td class="cl-db32102b"><p class="cl-db31f452"><span class="cl-db2f6500">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db321003"><p class="cl-db31f45a"><span class="cl-db2f6500">REMOTE</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">0</span></p></td><td class="cl-db32100c"><p class="cl-db31f452"><span class="cl-db2f6500">1 (33.3)</span></p></td></tr></tbody></table></div>
</div>
<div id="teae-incidence-table-by-soc-and-pt" class="section level2">
<h2>TEAE incidence table by SOC and PT</h2>
<pre class="r"><code>dataTEAE &lt;- subset(dataAll$ADAE, SAFFL == &quot;Y&quot; &amp; TRTEMFL == &quot;Y&quot;)
  
# order treatment and severity categories
dataTEAE$TRTA &lt;- with(dataTEAE, reorder(TRTA, TRTAN))

## data considered for the total
dataTotalAE &lt;- subset(dataAll$ADSL, SAFFL == &quot;Y&quot;)
dataTotalAE$TRTA &lt;- with(dataTotalAE, reorder(TRT01A, TRT01AN))

getSummaryStatisticsTable(
    data = dataTEAE,
    rowVar = c(&quot;AESOC&quot;, &quot;AEDECOD&quot;),
    colVar = &quot;TRTA&quot;,
    ## total
    # data
    dataTotal = dataTotalAE,
    # row total
    rowVarTotalInclude = c(&quot;AESOC&quot;, &quot;AEDECOD&quot;), rowTotalLab = &quot;Any TEAE&quot;,
    stats = getStats(&quot;n (%)&quot;),
    labelVars = labelVars,
    rowVarLab = c(&#39;AESOC&#39; = &quot;TEAE by SOC and Preferred Term,\nn (%)&quot;),
    # sort rows based on the total column:
    rowOrder = &quot;total&quot;, 
    rowOrderTotalFilterFct = function(x) subset(x, TRTA == &quot;Total&quot;),
    title = paste(&quot;Table: Treatment-emergent Adverse Events by System Organ Class&quot;,
        &quot;and Preferred Term (Safety Analysis Set)&quot;
    )
    # file = file.path(&quot;tables_CSR&quot;, &quot;Table_TEAE_SOCPT_atLeast1Subject.docx&quot;)
)</code></pre>
<div class="tabwid"><style>.cl-db7bf852{}.cl-db74cd16{font-family:'Times';font-size:8pt;font-weight:bold;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-db74cd2a{font-family:'Times';font-size:8pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-db776a1c{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db776a30{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db776a3a{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db776a44{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db776a45{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db776a4e{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-db778736{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db778740{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db77874a{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db778754{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db77875e{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db77875f{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db778768{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db778769{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db778772{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db77877c{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db778786{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-db778790{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}</style><table data-quarto-disable-processing='true' class='cl-db7bf852'><thead><tr style="overflow-wrap:break-word;"><th  colspan="4"class="cl-db778736"><p class="cl-db776a1c"><span class="cl-db74cd16">Table: Treatment-emergent Adverse Events by System Organ Class and Preferred Term (Safety Analysis Set)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-db77874a"><p class="cl-db776a1c"><span class="cl-db74cd16">TEAE by SOC and Preferred Term,</span><br><span class="cl-db74cd16">n (%)</span></p></th><th  rowspan="2"class="cl-db778754"><p class="cl-db776a30"><span class="cl-db74cd16">Placebo</span><br><span class="cl-db74cd16">(N=2)</span></p></th><th  rowspan="2"class="cl-db778754"><p class="cl-db776a30"><span class="cl-db74cd16">Xanomeline Low Dose</span><br><span class="cl-db74cd16">(N=2)</span></p></th><th  rowspan="2"class="cl-db778754"><p class="cl-db776a30"><span class="cl-db74cd16">Xanomeline High Dose</span><br><span class="cl-db74cd16">(N=3)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-db77875e"><p class="cl-db776a3a"><span class="cl-db74cd16">Dictionary-Derived Term</span></p></th></tr></thead><tbody><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a44"><span class="cl-db74cd2a">Any TEAE</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (100)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (100)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (100)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">APPLICATION SITE PRURITUS</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (100)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">APPLICATION SITE ERYTHEMA</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (100)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">APPLICATION SITE IRRITATION</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">APPLICATION SITE DERMATITIS</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">FATIGUE</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">SECRETION DISCHARGE</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">SUDDEN DEATH</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (100)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">BACK PAIN</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">FLANK PAIN</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">MUSCULAR WEAKNESS</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">SHOULDER PAIN</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">PSYCHIATRIC DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">COMPLETED SUICIDE</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">CONFUSIONAL STATE</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">HALLUCINATION, VISUAL</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">GASTROINTESTINAL DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">NAUSEA</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">INFECTIONS AND INFESTATIONS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">LOWER RESPIRATORY TRACT INFECTION</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">PNEUMONIA</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">NERVOUS SYSTEM DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">AMNESIA</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">LETHARGY</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">PARTIAL SEIZURES WITH SECONDARY GENERALISATION</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">RENAL AND URINARY DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">CALCULUS URETHRAL</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">INCONTINENCE</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">DYSPNOEA</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">EPISTAXIS</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">SKIN AND SUBCUTANEOUS TISSUE DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">ACTINIC KERATOSIS</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">ERYTHEMA</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">CARDIAC DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">MYOCARDIAL INFARCTION</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">INJURY, POISONING AND PROCEDURAL COMPLICATIONS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778786"><p class="cl-db776a4e"><span class="cl-db74cd2a">JOINT DISLOCATION</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778790"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">SKIN LACERATION</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">INVESTIGATIONS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">NASAL MUCOSA BIOPSY</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (50.0)</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778772"><p class="cl-db776a44"><span class="cl-db74cd2a">METABOLISM AND NUTRITION DISORDERS</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db77877c"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-db778768"><p class="cl-db776a4e"><span class="cl-db74cd2a">DECREASED APPETITE</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">0</span></p></td><td class="cl-db778769"><p class="cl-db776a45"><span class="cl-db74cd2a">1 (33.3)</span></p></td></tr></tbody></table></div>
</div>
<div id="events-occuring-in-at-least-25-of-all-subjects"
class="section level2">
<h2>Events occuring in at least 25% of all subjects</h2>
<pre class="r"><code>getSummaryStatisticsTable(
    data = dataTEAE,
    rowVar = c(&quot;AESOC&quot;, &quot;AEDECOD&quot;),
    colVar = &quot;TRTA&quot;,
    ## total
    # data
    dataTotal = dataTotalAE, 
    # row total
    rowVarTotalInclude = c(&quot;AESOC&quot;, &quot;AEDECOD&quot;), rowTotalLab = &quot;Any TEAE&quot;,
    stats = getStats(&quot;n (%)&quot;),
    labelVars = labelVars,
    rowVarLab = c(&#39;AESOC&#39; = &quot;SOC and Preferred Term,\nn (%)&quot;),
    # sort rows based on the total column:
    rowOrder = &quot;total&quot;, 
    rowOrderTotalFilterFct = function(x) subset(x, TRTA == &quot;Total&quot;),
    title = paste(&quot;Table: Treatment-emergent Adverse Events by System Organ Class&quot;,
        &quot;and Preferred Term reported in at least 25% of the subjects&quot;,
        &quot;in any treatment group (Safety Analysis Set)&quot;
    ),
    # file = file.path(&quot;tables_CSR&quot;, &quot;Table_TEAE_SOCPT_atLeast25PercentsSubject.docx&quot;),
    
    # include only events occuring in at least 25% for at least one preferred term:
    filterFct = function(x)
        ddply(x, &quot;AESOC&quot;, function(x){ # per AESOC to include the total
            ddply(x, &quot;AEDECOD&quot;, function(y){
                yTotal &lt;- subset(y, grepl(&quot;Total&quot;, TRTA))
                if(any(yTotal$statPercN &gt;= 25)) y
            })
        })
)</code></pre>
<div class="tabwid"><style>.cl-dbd54a9c{}.cl-dbcf815c{font-family:'Times';font-size:8pt;font-weight:bold;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-dbcf8170{font-family:'Times';font-size:8pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-dbd1eb54{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dbd1eb68{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dbd1eb72{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dbd1eb73{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dbd1eb7c{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dbd1eb86{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dbd204ea{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd204f4{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd204fe{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd20508{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd20512{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd2051c{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd20526{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd20527{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd20530{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd20531{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd2053a{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd2053b{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd20544{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dbd2054e{width:1.567in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}</style><table data-quarto-disable-processing='true' class='cl-dbd54a9c'><thead><tr style="overflow-wrap:break-word;"><th  colspan="4"class="cl-dbd204ea"><p class="cl-dbd1eb54"><span class="cl-dbcf815c">Table: Treatment-emergent Adverse Events by System Organ Class and Preferred Term reported in at least 25% of the subjects in any treatment group (Safety Analysis Set)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-dbd204fe"><p class="cl-dbd1eb54"><span class="cl-dbcf815c">SOC and Preferred Term,</span><br><span class="cl-dbcf815c">n (%)</span></p></th><th  rowspan="2"class="cl-dbd20508"><p class="cl-dbd1eb68"><span class="cl-dbcf815c">Placebo</span><br><span class="cl-dbcf815c">(N=2)</span></p></th><th  rowspan="2"class="cl-dbd20508"><p class="cl-dbd1eb68"><span class="cl-dbcf815c">Xanomeline Low Dose</span><br><span class="cl-dbcf815c">(N=2)</span></p></th><th  rowspan="2"class="cl-dbd20508"><p class="cl-dbd1eb68"><span class="cl-dbcf815c">Xanomeline High Dose</span><br><span class="cl-dbcf815c">(N=3)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-dbd20512"><p class="cl-dbd1eb72"><span class="cl-dbcf815c">Dictionary-Derived Term</span></p></th></tr></thead><tbody><tr style="overflow-wrap:break-word;"><td class="cl-dbd20526"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">Any TEAE</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (100)</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (100)</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20530"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS</span></p></td><td class="cl-dbd20531"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd20531"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (100)</span></p></td><td class="cl-dbd20531"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">3 (100)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd2053a"><p class="cl-dbd1eb86"><span class="cl-dbcf8170">APPLICATION SITE PRURITUS</span></p></td><td class="cl-dbd2053b"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2053b"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (100)</span></p></td><td class="cl-dbd2053b"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd2053a"><p class="cl-dbd1eb86"><span class="cl-dbcf8170">APPLICATION SITE ERYTHEMA</span></p></td><td class="cl-dbd2053b"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2053b"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (100)</span></p></td><td class="cl-dbd2053b"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20526"><p class="cl-dbd1eb86"><span class="cl-dbcf8170">APPLICATION SITE IRRITATION</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (50.0)</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20544"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (100)</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20544"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">PSYCHIATRIC DISORDERS</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (50.0)</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (50.0)</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20530"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">GASTROINTESTINAL DISORDERS</span></p></td><td class="cl-dbd20531"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd20531"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd20531"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20526"><p class="cl-dbd1eb86"><span class="cl-dbcf8170">NAUSEA</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd20527"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20544"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">INFECTIONS AND INFESTATIONS</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (50.0)</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20544"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">NERVOUS SYSTEM DISORDERS</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20544"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">RENAL AND URINARY DISORDERS</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (50.0)</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20544"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (50.0)</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dbd20544"><p class="cl-dbd1eb73"><span class="cl-dbcf8170">SKIN AND SUBCUTANEOUS TISSUE DISORDERS</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">0</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (50.0)</span></p></td><td class="cl-dbd2054e"><p class="cl-dbd1eb7c"><span class="cl-dbcf8170">1 (33.3)</span></p></td></tr></tbody></table></div>
</div>
<div id="teae-worst-case-table" class="section level2">
<h2>TEAE worst-case table</h2>
<pre class="r"><code># Simple capitalization function
simpleCap &lt;- function(x) {
  str_to_title(tolower(x))
}

# Extract analysis datasets
dataTEAE &lt;- subset(dataAll$ADAE, SAFFL == &quot;Y&quot; &amp; TRTEMFL == &quot;Y&quot;)
dataTEAE$TRTA &lt;- with(dataTEAE, reorder(TRTA, TRTAN))

# Total population for percentages (from ADSL)
dataTotalAE &lt;- subset(dataAll$ADSL, SAFFL == &quot;Y&quot;)
dataTotalAE$TRTA &lt;- with(dataTotalAE, reorder(TRT01A, TRT01AN))

# Set AE severity levels
dataTEAE$AESEV &lt;- factor(dataTEAE$AESEV, levels = c(&quot;MILD&quot;, &quot;MODERATE&quot;, &quot;SEVERE&quot;))
dataTEAE$AESEVN &lt;- as.numeric(dataTEAE$AESEV)

# Extract worst-case event per subject per AE term
dataAEWC &lt;- ddply(dataTEAE, c(&quot;AESOC&quot;, &quot;AEDECOD&quot;, &quot;USUBJID&quot;, &quot;TRTA&quot;), function(x) {
  x[which.max(x$AESEVN), ]
})

# Set WORSTINT with all severity levels included
dataAEWC$WORSTINT &lt;- factor(
  simpleCap(tolower(dataAEWC$AESEV)),
  levels = c(&quot;Mild&quot;, &quot;Moderate&quot;, &quot;Severe&quot;)
)
labelVars[&quot;WORSTINT&quot;] &lt;- &quot;Worst-case scenario&quot;

# Generate datasets for totals: by AEDECOD and by SOC
dataTotalRow &lt;- list(
  AEDECOD = ddply(dataAEWC, c(&quot;AESOC&quot;, &quot;USUBJID&quot;, &quot;TRTA&quot;), function(x) {
    x[which.max(x$AESEVN), ]
  }),
  AESOC = ddply(dataAEWC, c(&quot;USUBJID&quot;, &quot;TRTA&quot;), function(x) {
    x[which.max(x$AESEVN), ]
  })
)

# Ensure WORSTINT factor levels are preserved in total rows
dataTotalRow &lt;- lapply(dataTotalRow, function(df) {
  df$WORSTINT &lt;- factor(
    simpleCap(tolower(df$AESEV)),
    levels = c(&quot;Mild&quot;, &quot;Moderate&quot;, &quot;Severe&quot;)
  )
  df
})

# Build the table
getSummaryStatisticsTable(
  data = dataAEWC,
  rowVar = c(&quot;AESOC&quot;, &quot;AEDECOD&quot;, &quot;WORSTINT&quot;),
  rowVarInSepCol = &quot;WORSTINT&quot;,
  rowVarTotalInclude = c(&quot;AESOC&quot;, &quot;AEDECOD&quot;),
  dataTotalRow = dataTotalRow,
  rowVarTotalByVar = &quot;WORSTINT&quot;,
  rowTotalLab = &quot;Any TEAE&quot;,
  rowVarLab = c(
    AESOC = &quot;Subjects with, n(%):&quot;,
    WORSTINT = &quot;Worst-case scenario&quot;
  ),
  rowOrder = &quot;total&quot;,
  colVar = &quot;TRTA&quot;,
  stats = getStats(&quot;n (%)&quot;),
  emptyValue = &quot;0&quot;,
  labelVars = labelVars,
  dataTotal = dataTotalAE,
  title = tools::toTitleCase(
    paste(
      &quot;Table: Treatment-emergent Adverse&quot;,
      &quot;Events by system organ&quot;,
      &quot;and preferred term by worst-case (safety Analysis Set)&quot;
    )
  )
  # file = file.path(&quot;tables_CSR&quot;, &quot;Table_TEAE_Severity.docx&quot;)
)</code></pre>
<div class="tabwid"><style>.cl-dc5f5016{}.cl-dc571720{font-family:'Times';font-size:8pt;font-weight:bold;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-dc57173e{font-family:'Times';font-size:8pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-dc5a0462{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dc5a046c{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dc5a0476{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dc5a0477{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dc5a0480{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dc5a0481{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:0;padding-top:0;padding-left:14.4pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-dc5a23b6{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23c0{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23c1{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23ca{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23cb{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23d4{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23d5{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23de{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23df{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23e8{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23e9{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 1pt solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-dc5a23f2{width:1.254in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}</style><table data-quarto-disable-processing='true' class='cl-dc5f5016'><thead><tr style="overflow-wrap:break-word;"><th  colspan="5"class="cl-dc5a23b6"><p class="cl-dc5a0462"><span class="cl-dc571720">Table: Treatment-Emergent Adverse Events by System Organ and Preferred Term by Worst-Case (Safety Analysis Set)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-dc5a23c1"><p class="cl-dc5a0462"><span class="cl-dc571720">Subjects with, n(%):</span></p></th><th  rowspan="2"class="cl-dc5a23ca"><p class="cl-dc5a046c"><span class="cl-dc571720">Worst-case scenario</span></p></th><th  rowspan="2"class="cl-dc5a23ca"><p class="cl-dc5a046c"><span class="cl-dc571720">Placebo</span><br><span class="cl-dc571720">(N=2)</span></p></th><th  rowspan="2"class="cl-dc5a23ca"><p class="cl-dc5a046c"><span class="cl-dc571720">Xanomeline Low Dose</span><br><span class="cl-dc571720">(N=2)</span></p></th><th  rowspan="2"class="cl-dc5a23ca"><p class="cl-dc5a046c"><span class="cl-dc571720">Xanomeline High Dose</span><br><span class="cl-dc571720">(N=3)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-dc5a23cb"><p class="cl-dc5a0476"><span class="cl-dc571720">Dictionary-Derived Term</span></p></th></tr></thead><tbody><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23d5"><p class="cl-dc5a0477"><span class="cl-dc57173e">Any TEAE</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">2 (100)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="3"class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">2 (66.7)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">APPLICATION SITE PRURITUS</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">2 (100)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">APPLICATION SITE ERYTHEMA</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">2 (100)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">APPLICATION SITE IRRITATION</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">APPLICATION SITE DERMATITIS</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">FATIGUE</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">SECRETION DISCHARGE</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">SUDDEN DEATH</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">BACK PAIN</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">FLANK PAIN</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">MUSCULAR WEAKNESS</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">SHOULDER PAIN</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">PSYCHIATRIC DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">COMPLETED SUICIDE</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">CONFUSIONAL STATE</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">HALLUCINATION, VISUAL</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">NERVOUS SYSTEM DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">AMNESIA</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">LETHARGY</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">PARTIAL SEIZURES WITH SECONDARY GENERALISATION</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">GASTROINTESTINAL DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">NAUSEA</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">INFECTIONS AND INFESTATIONS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">LOWER RESPIRATORY TRACT INFECTION</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">PNEUMONIA</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">RENAL AND URINARY DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">CALCULUS URETHRAL</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">INCONTINENCE</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td  rowspan="2"class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">DYSPNOEA</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">EPISTAXIS</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">SKIN AND SUBCUTANEOUS TISSUE DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">ACTINIC KERATOSIS</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">ERYTHEMA</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">INJURY, POISONING AND PROCEDURAL COMPLICATIONS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23f2"><p class="cl-dc5a0481"><span class="cl-dc57173e">JOINT DISLOCATION</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23de"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">SKIN LACERATION</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">CARDIAC DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">MYOCARDIAL INFARCTION</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Severe</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">INVESTIGATIONS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">NASAL MUCOSA BIOPSY</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Mild</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (50.0)</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23e8"><p class="cl-dc5a0477"><span class="cl-dc57173e">METABOLISM AND NUTRITION DISORDERS</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23e9"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-dc5a23d5"><p class="cl-dc5a0481"><span class="cl-dc57173e">DECREASED APPETITE</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">Moderate</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">0</span></p></td><td class="cl-dc5a23df"><p class="cl-dc5a0480"><span class="cl-dc57173e">1 (33.3)</span></p></td></tr></tbody></table></div>
</div>
</div>
<div id="ae-visualization" class="section level1">
<h1>AE Visualization</h1>
<div id="relative-riskforest-plot" class="section level2">
<h2>Relative Risk/Forest Plot</h2>
<pre class="r"><code>load(file = &quot;./01_Datasets/adae.rda&quot;)
load(file = &quot;./01_Datasets/adsl.rda&quot;)

### Subset the population dataset ADSL on SAFFL safety flag 
### consider only two treatments for comparison.
### convert all the upcase variables in ADSL and ADAE to lower case
adsl2  &lt;- adsl %&gt;% 
  rename_with(tolower) %&gt;%
  filter(saffl==&#39;Y&#39; &amp; trt01a==c(&#39;Xan_Hi&#39;,&#39;Pbo&#39;)) %&gt;%         
  select(usubjid,saffl,trt01a)
  
adae2  &lt;- adae %&gt;% rename_with(tolower) 

adsl_cnt2 &lt;- adsl2 %&gt;% 
  group_by(trt01a) %&gt;% 
  dplyr::summarise(bign=n()) %&gt;%
  pivot_wider(names_from = trt01a, values_from = bign) 

### separate variables/macro variable to store those values two treatment counts
adsl_cnt2</code></pre>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["Pbo"],"name":[1],"type":["int"],"align":["right"]},{"label":["Xan_Hi"],"name":[2],"type":["int"],"align":["right"]}],"data":[{"1":"44","2":"43"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
<pre class="r"><code>pbo &lt;- adsl_cnt2$Pbo
xan &lt;- adsl_cnt2$Xan_Hi 

### Merge the ADSL and ADAE on usubjid variable, keep only the required variables and remove the duplicate records, group by treatment and aedecod. Get the count of each aedecod per treatment and then derive the percentage. While deriving the population we are using the macro variables pbo and xan which has the population bign count.
adsl_adae = inner_join(adsl2,adae2,by=c(&quot;usubjid&quot;)) %&gt;% 
  select(usubjid,aedecod,trt01a.x)  %&gt;%
  distinct(usubjid,aedecod,trt01a.x) %&gt;% 
  group_by(trt01a.x,aedecod) %&gt;% 
  dplyr::summarise(cnt=n(),.groups = &#39;drop&#39;) %&gt;% 
  ungroup() %&gt;% 
  mutate(pct=ifelse(trt01a.x==&#39;Pbo&#39;,cnt/pbo,cnt/xan)) %&gt;% 
  ungroup() %&gt;% 
  arrange(aedecod,trt01a.x) 

### Derive the mean relative risk, lcl and ucl 
adsl_adae2 &lt;- adsl_adae %&gt;% 
  select(-pct) %&gt;% 
  pivot_wider(names_from = c(trt01a.x), values_from = cnt) %&gt;%
  mutate(nb=Pbo, na=Xan_Hi, snb=pbo, sna=xan, a=na/sna,
         b=nb/snb,factor=1.96*sqrt(a*(1-a)/sna + b*(1-b)/snb),
         lcl=a-b-factor,ucl=a-b+factor,mean=0.5*(lcl+ucl)) %&gt;% 
  filter(!is.na(mean)) 


### Plot 1: AE Proportion dot plot
ggplot(adsl_adae %&gt;% filter(aedecod %in% adsl_adae2$aedecod) %&gt;%
         arrange(desc(aedecod)),aes(x=pct,y=reorder(aedecod,desc(aedecod)))) + 
  geom_point(shape = 17,size=2,aes(colour = factor(trt01a.x))) +
  ggtitle(&quot;Proportion&quot;) +
  xlab(&#39;Proportion&#39;) + ylab(&#39;&#39;) +
  scale_colour_manual(values = c(&quot;Blue&quot;, &quot;Red&quot;)) +
  theme(legend.position=&quot;bottom&quot;) + labs(col=&quot;Treatment:&quot;) </code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-5-1.png" width="672" /></p>
<pre class="r"><code>### Plot 2: Relative Risk
ggplot(data=adsl_adae2, aes(x=reorder(aedecod,desc(aedecod)), y=mean, ymin=lcl, ymax=ucl)) +
  geom_pointrange() + 
  geom_hline(yintercept=0, lty=2) +  # add a dotted line at x=1 after flip
  coord_flip() +  # flip coordinates (puts labels on y axis)
  xlab(&quot;&quot;) + ylab(&quot;Mean (95% CI)&quot;) +
  ggtitle(&quot;Risk Difference with 0.95CI&quot;) +
  theme(axis.ticks = element_blank(),legend.position=&quot;none&quot;)</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-5-2.png" width="672" /></p>
<pre class="r"><code>### align the above two images side by side, use the package cowplot.
p2 &lt;- ggplot(data=adsl_adae2, aes(x=reorder(aedecod,desc(aedecod)), y=mean, ymin=lcl, ymax=ucl)) +
  geom_pointrange() + 
  geom_hline(yintercept=0, lty=2) +  # add a dotted line at x=1 after flip
  coord_flip() +  # flip coordinates (puts labels on y axis)
  xlab(&quot;&quot;) + ylab(&quot;Mean (95% CI)&quot;) +
  ggtitle(&quot;Risk Difference with 0.95CI&quot;) +
  theme(axis.text.y = element_blank(),axis.ticks = element_blank(),legend.position=&quot;none&quot;)

p1 &lt;- ggplot(adsl_adae %&gt;% filter(aedecod %in% adsl_adae2$aedecod) %&gt;% 
         arrange(desc(aedecod)),aes(x=pct,y=reorder(aedecod,desc(aedecod)))) + 
  geom_point(shape = 17,size=2,aes(colour = factor(trt01a.x))) +
  ggtitle(&quot;Proportion&quot;) +
  xlab(&#39;Proportion&#39;) + ylab(&#39;&#39;) +
  scale_colour_manual(values = c(&quot;Blue&quot;, &quot;Red&quot;)) +
  theme(legend.position=&quot;bottom&quot;) + labs(col=&quot;Treatment:&quot;)

plot_grid(p1,  p2, labels = &quot;AUTO&quot;,nrow = 1,rel_widths = c(0.8, 0.5))</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-5-3.png" width="672" /></p>
</div>
<div id="ae-rate-and-difference" class="section level2">
<h2>AE Rate and Difference</h2>
<p><em>The data is an excerpt of the official VAERS data created by US
Food and Drug Administration (FDA) and Centers for Disease Control and
Prevention (CDC) that may be associated with vaccines.</em></p>
<p><img src="02_Plots/Visualization/AEs/AE_DiffRate.png" /></p>
</div>
<div id="heat-map" class="section level2">
<h2>Heat Map</h2>
<p>Using a heatmap to display adverse event (AE) co-occurrence can be an
effective visual tool in medical research to identify and analyze
patterns of symptoms or side effects that frequently appear
together.</p>
<p>Heat maps are charts with values being represented by colors. The
intensity of the color is an indication of the number i.e. higher the
value more intense will be the color.</p>
<p><strong>HEAT MAP FOR NUMBER OF ADVERSE EVENTS PER TREATMENT PER
SYSTEM ORGAN CLASS (SOC):</strong></p>
<p>A heat map can be generated to visualize the number of adverse events
recorded per SOC per treatment. We will plot the treatments on x-axis
and the SOCs on y-axis. Each tile of the heat map will be colored as per
the number of events recorded for that particular combination. The color
of the tile will vary from yellow to red, with low counts shown in
yellow and high counts in red. The tiles with white color denote the
absence of events for a particular combination of SOC and treatment. The
number of events will be printed in either black or white as per a
predefined threshold; counts below or equal to the threshold will be
printed in black, remaining will be in white.</p>
<p>In this plot, we are able to see the number of events reported for
every SOC for all 5 arms. As seen in the legend, tiles with count less
than 100 are yellow with varying intensity as per the actual count for
that tile. For e.g. if we check the number of adverse events in the
gastrointestinal system for treatments X and Y, the count is 11 and 26
respectively. The color of the tile for Y is deeper than the tile for X.
The color starts changing from yellow to orange and then to red as the
number of events increases. This is observed in the “Psychiatric” SOC
counts, with 31 events Y has a yellow tile, 257 events lead to treatment
A having an orange tile and the treatment Z has a red tile due to the
311 events reported. Here the threshold for number of events has been
set to 100. We can quickly identify the SOCs with number of events
greater than 100 as they are printed in white. We can observe white
tiles for SOCs with no events for a particular treatment like
Reproductive system and treatment X.</p>
<p><img src="./02_Plots/Visualization/AEs/AE_Heat%20Map%201.png" /></p>
<pre class="r"><code># tb1 &lt;-aggregate(USUBJID~TRTA+SOC, data=aeord, FUN=function(x) c(ln=length(x)))
# head(tb1)
# names(tb1)[names(tb1)==&quot;USUBJID&quot;]&lt;- &quot;OBS&quot;

tb1 &lt;- data.frame(
  TRTA = c(&quot;Y&quot;, &quot;X&quot;, &quot;Z&quot;, &quot;A&quot;, &quot;B&quot;, &quot;Y&quot;, &quot;X&quot;, &quot;B&quot;, &quot;A&quot;),
  SOC = c(&quot;NERVOUS&quot;, &quot;NERVOUS&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;RENAL&quot;, &quot;RENAL&quot;),
  OBS = c(27, 12, 311, 257, 219, 31, 14, 17, 7)
)

p1 &lt;- ggplot(tb1, (aes(x = TRTA, y = SOC, fill=OBS))) + geom_raster() +
geom_text(aes(label = paste0(&quot;N=&quot;,round(OBS, 1)), color = OBS &lt; 100),show.legend = F)+
scale_fill_gradient(low=&quot;yellow&quot;,high=&quot;red&quot;,na.value=&quot;white&quot;)+
scale_color_manual(values = c(&quot;FALSE&quot; = &quot;white&quot;, &quot;TRUE&quot; = &quot;black&quot;)) +
scale_x_discrete(&quot;Treatment&quot;) + scale_y_discrete(&quot;System Organ Class&quot;) +
 theme_classic()+ggtitle(&quot;Heatmap for Number of Adverse Events per Treatment per SOC&quot;)+
 theme(plot.title = element_text(hjust = 0.5)) + labs(fill=&quot;Number of Events&quot;)
p1</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-6-1.png" width="672" /></p>
<p><strong>HEAT MAP FOR NUMBER OF SERIOUS AND NON SERIOUS ADVERSE EVENTS
PER SOC PER TREATMENT</strong></p>
<p>The adverse events are classified as either ‘Non Serious’ or
‘Serious’. We can plot the number of serious and non serious events
occurring per SOC per treatment as shown in the heat map below. In this
plot, both the counts will be displayed in the same tile and the color
of the tile will be decided by the maximum of the number of events if
both events are present.</p>
<p><img src="./02_Plots/Visualization/AEs/AE_Heat%20Map%202.png" /></p>
<p><strong>HEAT MAP FOR NUMBER OF ADVERSE EVENTS PER TREATMENT PER
PREFERRED TERM (PT) FOR A SINGLE SOC</strong></p>
<p>As mentioned earlier, we can analyze the psychiatric disorders
further by generating a heat map of the events reported under this SOC
for all treatments. We will generate a heat map of all PTs with number
of reported events greater than 10.</p>
<p><img src="./02_Plots/Visualization/AEs/AE_Heat%20Map%203.png" /></p>
<!-- sub <- subset(aeord,aeord$SOC=="PSYCHIATRIC") -->
<!-- tb4 <-aggregate(USUBJID~TRTA+AEDECOD, data=sub, FUN=function(x) c(ln=length(x))) -->
<!-- names(tb4)[names(tb4)=="USUBJID"]<- "OBS" -->
<!-- p3 <- ggplot(tb4[tb4$OBS>10,], (aes(x = TRTA, y = AEDECOD, fill = OBS))) + geom_raster() + -->
<!-- geom_text(aes(label = paste0("N=",round(OBS, 1)), color = OBS < 40), show.legend = -->
<!-- F,size=4)+ scale_fill_gradient(low="yellow",high="red",na.value="white")+ -->
<!-- scale_color_manual(values = c("FALSE" = "white", "TRUE" = "black")) + -->
<!-- scale_x_discrete("Treatment") + scale_y_discrete(name = "Adverse Event Term") + -->
<!--  theme_classic()+ -->
<!-- ggtitle("Heat Map for Number of Adverse Events per Treatment per Preferred Term for -->
<!-- Psychiatric Disorders") + theme(plot.title = element_text(hjust = 0.5)) + -->
<!--  labs(fill="Number of Events") -->
<!-- p3 -->
<pre class="r"><code># tb2 &lt;- aggregate(USUBJID~TRTA+SOC+AESER, data=aeord, FUN=function(x) c(ln=length(x)))
# names(tb2)[names(tb2)==&quot;USUBJID&quot;]&lt;- &quot;OBS&quot;
tb2 &lt;- data.frame(
  TRTA = c(&quot;Y&quot;, &quot;X&quot;, &quot;Z&quot;, &quot;A&quot;, &quot;B&quot;, &quot;Y&quot;, &quot;X&quot;, &quot;B&quot;, &quot;A&quot;),
  SOC = c(&quot;NERVOUS&quot;, &quot;NERVOUS&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;PSYCHIATRIC&quot;, &quot;RENAL&quot;, &quot;RENAL&quot;),
  AESER = c(&quot;Y&quot;,&quot;Y&quot;,&quot;N&quot;,&quot;N&quot;,&quot;Y&quot;,&quot;N&quot;,&quot;Y&quot;,&quot;N&quot;,&quot;Y&quot;),
  OBS = c(27, 12, 311, 257, 219, 31, 14, 17, 7)
)

tb3 &lt;-tb2[order(tb2$TRTA, tb2$SOC, tb2$OBS),]
p2 &lt;- ggplot(tb3, aes(TRTA, SOC, fill = OBS)) + geom_raster() +
geom_text(data=tb3[tb3$AESER==&quot;N&quot;,],aes(label = paste0(&quot;NSER=&quot;,round(OBS, 1))),
show.legend = F,size=2.9, vjust=0, hjust=1) +
geom_text(data=tb3[tb3$AESER==&quot;Y&quot;,],aes(label = paste0(&quot;SER=&quot;,round(OBS, 1))),
show.legend = F,size=2.9, vjust=1, hjust=0)+
scale_fill_gradient(low=&quot;yellow&quot;,high=&quot;red&quot;,na.value=&quot;white&quot;)+
scale_x_discrete(&quot;Treatment&quot;) + scale_y_discrete(name = &quot;System Organ Class&quot;) +
theme_classic()+
ggtitle(&quot;Heatmap for Number of Serious and Non Serious Adverse Events per SOC per
Treatment&quot;) + theme(plot.title = element_text(hjust = 0.5)) + labs(fill=&quot;Number of
Events&quot;)
p2</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-7-1.png" width="672" /></p>
<p><strong>HEAT MAP FOR NUMBER OF ADVERSE EVENTS OF PTS OF A SINGLE SOC
OF A SINGLE TREATMENT PER SEVERITY</strong></p>
<p>We can check the severity of all the PTs for a single SOC for a
single treatment. Let us analyze the Psychiatric Disorder PTs reported
for treatment Z. We will plot the number of events reported for PTs
against their severity which will have the value as Mild, Moderate or
Severe</p>
<p><img src="./02_Plots/Visualization/AEs/AE_Heat%20Map%204.png" /></p>
<!-- sub1 <- subset(aeord,aeord$SOC=="PSYCHIATRIC" & TRTA=="Z") -->
<!-- tb5 <- aggregate(USUBJID~AEDECOD+AESEV, data=sub1, FUN=function(x) c(ln=length(x))) -->
<!-- names(tb5)[names(tb5)=="USUBJID"]<- "OBS" -->
<!-- p4 <- ggplot(tb5, aes(AESEV, AEDECOD, fill = OBS)) + geom_raster() + -->
<!-- geom_text(aes(label=paste0("N=",round(OBS,1)),color=OBS<10), show.legend = F,size=3)+ -->
<!-- scale_fill_gradient(low="yellow",high="red",na.value="white")+ -->
<!-- scale_color_manual(values = c("FALSE" = "white", "TRUE" = "black")) + -->
<!-- scale_x_discrete("Severity") + scale_y_discrete(name = "Adverse Event Term") + -->
<!-- theme_classic()+ ggtitle("Heat Map for Number of Adverse Events of PTs of Psychiatric -->
<!-- Disorders of Treatment Z per Severity") + theme(plot.title = element_text(hjust = -->
<!-- 0.5)) + labs(fill="Number of Events") -->
<!-- p4 -->
<p><strong>HEAT MAP FOR NUMBER OF RELATED AND NOT RELATED ADVERSE EVENTS
PER PT PER SEVERITY FOR A SINGLE TREATMENT</strong></p>
<p>We can check the causality of the events reported in the above plot
along with their severity. Let us once again consider the psychiatry PTs
reported for treatment Z. We will plot the number of events reported for
PTs with their causality which will have values as ‘Related’ or ‘Not
Related’ against severity</p>
<p><img src="./02_Plots/Visualization/AEs/AE_Heat%20Map%205.png" /></p>
<!-- tb6 <- aggregate(USUBJID~AEDECOD+AESEV+AEREL, data=sub1, FUN=function(x) c(ln=length(x))) -->
<!-- names(tb6)[names(tb6)=="USUBJID"]<- "OBS" -->
<!-- tb6 <-tb6[order(tb6$AEDECOD,tb6$AESEV, tb6$OBS),] -->
<!-- p5 <- ggplot(tb6, aes(AESEV, AEDECOD, fill = OBS)) + geom_raster() + -->
<!-- geom_text(data=tb6[tb6$AEREL=="NOT RELATED",],aes(label=paste0("NREL=",round(OBS,1))), -->
<!-- show.legend = F,size=2.8, vjust=0, hjust=1) + -->
<!-- geom_text(data=tb6[tb6$AEREL=="RELATED",],aes(label = paste0("REL=",round(OBS, 1))), -->
<!-- show.legend = F,size=2.8, vjust=1, hjust=0)+ -->
<!-- scale_fill_gradient(low="yellow",high="red",na.value="white")+ -->
<!-- scale_x_discrete("Severity") + scale_y_discrete(name = "Adverse Event Term") + -->
<!-- theme_classic()+ -->
<!-- ggtitle("Heat Map for Number of Related and Not Related Adverse Events per PT per -->
<!-- Severity for Psychiatric Disorders of Treatment Z") + theme(plot.title = -->
<!-- element_text(hjust = 0.5)) + labs(fill="Number of Events") -->
<!-- p5 -->
<p><em>Source: <a
href="https://www.lexjansen.com/phuse/2018/dv/DV11.pdf"
class="uri">https://www.lexjansen.com/phuse/2018/dv/DV11.pdf</a></em></p>
</div>
<div id="volcano-plot" class="section level2">
<h2>Volcano Plot</h2>
<p>A volcano plot is a type of scatter-plot that is used to quickly
identify changes in large data sets composed of replicate data. It plots
significance versus fold-change on the y and x axes, respectively. It is
constructed by plotting the negative log of the p value on the y axis
(usually base 10). This results in data points with low p values (highly
significant) appearing toward the top of the plot. The x axis is the log
of the fold change between the two conditions. The log of the fold
change is used so that changes in both directions appear equidistant
from the center. In the clinical domain, a volcano plot is used to view
Risk Difference (RD), Relative Risk or Odds Ratio of AE occurrence
between the treatment groups by preferred term.</p>
<p><img src="02_Plots/Visualization/AEs/Volcano.png" /></p>
<p><strong>VOLCANO PLOT OF TREATMENT EMERGENT ADVERSE EVENT AT PT
LEVEL</strong></p>
<p>Volcano plots are also generated on the same data which is used for
heat maps. Here, we have plotted negative log10-transformed p-value
calculated using Fisher exact test on Y-axis and Log2-transformed
relative risk on x-axis.</p>
<p>The dashed red line on y-axis shows where p = 0.05 with points above
the line having p &lt; 0.05 and points below the line having p &gt;
0.05. Note that smaller the p-value larger is the number on y-axis. For
this graph, we have labeled the AE terms with p-values &lt; 0.05 as they
are significant.</p>
<pre class="r"><code># Set the seed for reproducibility
set.seed(123)

# Create a data frame with synthetic data
total &lt;- data.frame(
  AETERM = c(&quot;NECK SHOULDER PAIN&quot;, &quot;SINUSITIS&quot;, &quot;DECREASED APPETITE&quot;, &quot;DRY MOUTH&quot;, &quot;UPPER RESPIRATORY INFECTION&quot;,
             &quot;COLD SYMPTOMS&quot;, &quot;DRYNESS IN MOUTH&quot;, &quot;WEIGHT GAIN&quot;, &quot;HYPERHIDROSIS&quot;, &quot;INCREASED IRRITABILITY&quot;,
             &quot;INCREASED THIRST&quot;, &quot;LOWER BACK PAIN&quot;, &quot;NUMBNESS (BOTH HANDS)&quot;),
  rr = runif(13, 0.1, 6),  # Uniform distribution between 0.01 and 6
  log2rr = log(runif(13, 0.1, 6), 2),  # Normal distribution with mean -3 and sd 1
  p = runif(13, 0.0001, 0.1),  # Uniform distribution for p-values
  Total = sample(2:50, 13, replace = TRUE),  # Random sampling for total count
  term = c(NA, NA, &quot;DECREASED APPETITE&quot;, &quot;DRY MOUTH&quot;, NA, NA, NA, NA, NA, NA, NA, NA, NA)
) 

total %&gt;%
  kable(caption = &quot;DATA SNIPPET&quot;, format = &quot;html&quot;) %&gt;%
  kable_styling(latex_options = &quot;striped&quot;)</code></pre>
<table class="table" style="margin-left: auto; margin-right: auto;">
<caption>
DATA SNIPPET
</caption>
<thead>
<tr>
<th style="text-align:left;">
AETERM
</th>
<th style="text-align:right;">
rr
</th>
<th style="text-align:right;">
log2rr
</th>
<th style="text-align:right;">
p
</th>
<th style="text-align:right;">
Total
</th>
<th style="text-align:left;">
term
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
NECK SHOULDER PAIN
</td>
<td style="text-align:right;">
1.7967074
</td>
<td style="text-align:right;">
1.7984807
</td>
<td style="text-align:right;">
0.0544522
</td>
<td style="text-align:right;">
13
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
SINUSITIS
</td>
<td style="text-align:right;">
4.7510003
</td>
<td style="text-align:right;">
-0.4996963
</td>
<td style="text-align:right;">
0.0594548
</td>
<td style="text-align:right;">
16
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
DECREASED APPETITE
</td>
<td style="text-align:right;">
2.5129638
</td>
<td style="text-align:right;">
2.4353532
</td>
<td style="text-align:right;">
0.0289871
</td>
<td style="text-align:right;">
33
</td>
<td style="text-align:left;">
DECREASED APPETITE
</td>
</tr>
<tr>
<td style="text-align:left;">
DRY MOUTH
</td>
<td style="text-align:right;">
5.3098027
</td>
<td style="text-align:right;">
0.6340520
</td>
<td style="text-align:right;">
0.0147967
</td>
<td style="text-align:right;">
43
</td>
<td style="text-align:left;">
DRY MOUTH
</td>
</tr>
<tr>
<td style="text-align:left;">
UPPER RESPIRATORY INFECTION
</td>
<td style="text-align:right;">
5.6487570
</td>
<td style="text-align:right;">
-1.5222139
</td>
<td style="text-align:right;">
0.0963061
</td>
<td style="text-align:right;">
46
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
COLD SYMPTOMS
</td>
<td style="text-align:right;">
0.3687833
</td>
<td style="text-align:right;">
1.0248390
</td>
<td style="text-align:right;">
0.0902397
</td>
<td style="text-align:right;">
8
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
DRYNESS IN MOUTH
</td>
<td style="text-align:right;">
3.2158224
</td>
<td style="text-align:right;">
2.5189308
</td>
<td style="text-align:right;">
0.0691015
</td>
<td style="text-align:right;">
10
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
WEIGHT GAIN
</td>
<td style="text-align:right;">
5.3652724
</td>
<td style="text-align:right;">
2.4190755
</td>
<td style="text-align:right;">
0.0795672
</td>
<td style="text-align:right;">
42
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
HYPERHIDROSIS
</td>
<td style="text-align:right;">
3.3534666
</td>
<td style="text-align:right;">
2.0661030
</td>
<td style="text-align:right;">
0.0025589
</td>
<td style="text-align:right;">
11
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
INCREASED IRRITABILITY
</td>
<td style="text-align:right;">
2.7940269
</td>
<td style="text-align:right;">
1.9556811
</td>
<td style="text-align:right;">
0.0478318
</td>
<td style="text-align:right;">
24
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
INCREASED THIRST
</td>
<td style="text-align:right;">
5.7453167
</td>
<td style="text-align:right;">
2.5768103
</td>
<td style="text-align:right;">
0.0758701
</td>
<td style="text-align:right;">
28
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LOWER BACK PAIN
</td>
<td style="text-align:right;">
2.7746715
</td>
<td style="text-align:right;">
1.9886535
</td>
<td style="text-align:right;">
0.0217192
</td>
<td style="text-align:right;">
8
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
NUMBNESS (BOTH HANDS)
</td>
<td style="text-align:right;">
4.0976667
</td>
<td style="text-align:right;">
2.0977219
</td>
<td style="text-align:right;">
0.0318863
</td>
<td style="text-align:right;">
28
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<pre class="r"><code>#Make a basic volcano plot
with(total, plot(log2rr, -log10(p), pch=20, main=&quot;Volcano Plots of Treatment Emergent Adverse
Events at PT Level&quot;, xlim=c(-8.5,8), abline(h = 1.3, col=&quot;red&quot;, lty=2), xlab=&quot;Log2 (Relative
Risk)&quot;, ylab=&quot;-Log10 (p-value)&quot;))
#Add colored points: red if padj&lt;0.05, orange of log2rr&gt;1, green if both)
with(subset(total, p&lt;.05 ), points(log2rr, -log10(p), pch=20, col=&quot;red&quot;))
with(subset(total, abs(log2rr)&gt;1), points(log2rr, -log10(p), pch=20, col=&quot;orange&quot;))
with(subset(total, p&lt;.05 &amp; abs(log2rr)&gt;1), points(log2rr, -log10(p), pch=20, col=&quot;green&quot;))

#Label points with the textxy function from the calibrate plot
with(subset(total, p&lt;.05 &amp; abs(log2rr)&gt;1), textxy(log2rr, -log10(p), labs=AETERM, cex=.7))</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-8-1.png" width="672" /></p>
</div>
<div id="bubble-plot" class="section level2">
<h2>Bubble Plot</h2>
<p><strong>BUBBLE PLOT OF -LOG10 (P-VALUE) BY RELATIVE RISK SIZED BY
COUNTS</strong></p>
<p>The x-axis represents the log2 relative risk and y-axis represents
the –log10 p-values computed using the fisher exact test. Each bubble
represents an adverse event, with bubble size indicative of the total
number of adverse events that occur for both treatments combined.
Specifically, the bubble area is proportional to the total number of
events.</p>
<p>Log2 (Relative Risk) of 0 represents no difference in risk between
the 2 treatment groups, while bubbles to the right indicate a higher
risk for subjects in treatment group Y (i.e. – If Log2 (RR) = 1, that is
the same as an RR=2), and bubbles to the left indicate a higher risk for
subjects in treatment group Z. Color, green and blue helps to emphasize
adverse events that are more common for treatment Y or Z, respectively.
The size of the bubble represents the total number of occurrences of the
AE of interest. Names of events with total number of occurrences greater
than 10 are displayed.</p>
<pre class="r"><code>p &lt;-plot_ly(total, x = ~ log2rr, y = ~ -log10(p), text = ~ AETERM, type = &#39;scatter&#39;, mode =
&#39;markers&#39;, color=~ log2rr, colors=c(&quot;blue&quot;,&quot;green&quot;) , marker = list(size = ~ Total, opacity =
0.9)) %&gt;%
layout(title = &#39;Bubble Plot Treatment Emergent Adverse Event of Significance versus Relative
Risk&#39;, xaxis = list(showgrid = FALSE, title = &#39;Log2 (Relative Risk)&#39;), yaxis = list(showgrid
= FALSE, title = &#39;-Log10 (p-value)&#39;)) %&gt;%
add_annotations(x = total$log2rr, y = total$p1, text = total$term, xref = &quot;x&quot;, yref = &quot;y&quot;,
 showarrow = FALSE, font = list(size = 10))
p</code></pre>
<div class="plotly html-widget html-fill-item" id="htmlwidget-dfa5d821dc44474b3e8c" style="width:672px;height:480px;"></div>
<script type="application/json" data-for="htmlwidget-dfa5d821dc44474b3e8c">{"x":{"visdat":{"3583282a7ad":["function () ","plotlyVisDat"]},"cur_data":"3583282a7ad","attrs":{"3583282a7ad":{"x":{},"y":{},"text":{},"mode":"markers","marker":{"size":{},"opacity":0.90000000000000002},"color":{},"colors":["blue","green"],"alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter"}},"layout":{"margin":{"b":40,"l":60,"t":25,"r":10},"title":"Bubble Plot Treatment Emergent Adverse Event of Significance versus Relative<br />Risk","xaxis":{"domain":[0,1],"automargin":true,"showgrid":false,"title":"Log2 (Relative Risk)"},"yaxis":{"domain":[0,1],"automargin":true,"showgrid":false,"title":"-Log10 (p-value)"},"annotations":[{"text":null,"x":1.7984806959087485,"y":1.2639846019611922,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":-0.49969634350375841,"y":1.225813166277796,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":"DECREASED APPETITE","x":2.4353531824483436,"y":1.5377958641655511,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":"DRY MOUTH","x":0.63405198918775807,"y":1.8298365000665657,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":-1.522213900615502,"y":1.016346109984575,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":1.0248389586175237,"y":1.0446024793675117,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":2.5189307633519533,"y":1.160512793480508,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":2.4190755272227609,"y":1.0992659518018075,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":2.0661030045451168,"y":2.5919454836768852,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":1.9556811314634255,"y":1.320283116504829,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":2.5768103293901206,"y":1.119929298876813,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":1.9886535023326743,"y":1.6631571195022936,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}},{"text":null,"x":2.0977219480164111,"y":1.4963961083258459,"xref":"x","yref":"y","showarrow":false,"font":{"size":10}}],"hovermode":"closest","showlegend":false,"legend":{"yanchor":"top","y":0.5}},"source":"A","config":{"modeBarButtonsToAdd":["hoverclosest","hovercompare"],"showSendToCloud":false},"data":[{"x":[1.7984806959087485,-0.49969634350375841,2.4353531824483436,0.63405198918775807,-1.522213900615502,1.0248389586175237,2.5189307633519533,2.4190755272227609,2.0661030045451168,1.9556811314634255,2.5768103293901206,1.9886535023326743,2.0977219480164111],"y":[1.2639846019611922,1.225813166277796,1.5377958641655511,1.8298365000665657,1.016346109984575,1.0446024793675117,1.160512793480508,1.0992659518018075,2.5919454836768852,1.320283116504829,1.119929298876813,1.6631571195022936,1.4963961083258459],"text":["NECK SHOULDER PAIN","SINUSITIS","DECREASED APPETITE","DRY MOUTH","UPPER RESPIRATORY INFECTION","COLD SYMPTOMS","DRYNESS IN MOUTH","WEIGHT GAIN","HYPERHIDROSIS","INCREASED IRRITABILITY","INCREASED THIRST","LOWER BACK PAIN","NUMBNESS (BOTH HANDS)"],"mode":"markers","marker":{"colorbar":{"title":"log2rr","ticklen":2},"cmin":-1.522213900615502,"cmax":2.5768103293901206,"colorscale":[["0","rgba(0,0,255,1)"],["0.0416666666666667","rgba(49,29,248,1)"],["0.0833333333333334","rgba(69,45,241,1)"],["0.125","rgba(83,58,233,1)"],["0.166666666666667","rgba(93,70,226,1)"],["0.208333333333333","rgba(102,81,219,1)"],["0.25","rgba(108,91,211,1)"],["0.291666666666667","rgba(113,101,204,1)"],["0.333333333333333","rgba(118,110,197,1)"],["0.375","rgba(121,120,189,1)"],["0.416666666666667","rgba(123,129,182,1)"],["0.458333333333333","rgba(125,138,174,1)"],["0.5","rgba(125,147,166,1)"],["0.541666666666667","rgba(125,156,158,1)"],["0.583333333333333","rgba(124,165,150,1)"],["0.625","rgba(123,174,141,1)"],["0.666666666666667","rgba(120,183,133,1)"],["0.708333333333333","rgba(116,192,124,1)"],["0.75","rgba(111,201,114,1)"],["0.791666666666667","rgba(105,210,104,1)"],["0.833333333333333","rgba(97,219,92,1)"],["0.875","rgba(87,228,79,1)"],["0.916666666666667","rgba(73,237,64,1)"],["0.958333333333333","rgba(52,246,44,1)"],["1","rgba(0,255,0,1)"]],"showscale":false,"color":[1.7984806959087485,-0.49969634350375841,2.4353531824483436,0.63405198918775807,-1.522213900615502,1.0248389586175237,2.5189307633519533,2.4190755272227609,2.0661030045451168,1.9556811314634255,2.5768103293901206,1.9886535023326743,2.0977219480164111],"size":[13,16,33,43,46,8,10,42,11,24,28,8,28],"opacity":0.90000000000000002,"line":{"colorbar":{"title":"","ticklen":2},"cmin":-1.522213900615502,"cmax":2.5768103293901206,"colorscale":[["0","rgba(0,0,255,1)"],["0.0416666666666667","rgba(49,29,248,1)"],["0.0833333333333334","rgba(69,45,241,1)"],["0.125","rgba(83,58,233,1)"],["0.166666666666667","rgba(93,70,226,1)"],["0.208333333333333","rgba(102,81,219,1)"],["0.25","rgba(108,91,211,1)"],["0.291666666666667","rgba(113,101,204,1)"],["0.333333333333333","rgba(118,110,197,1)"],["0.375","rgba(121,120,189,1)"],["0.416666666666667","rgba(123,129,182,1)"],["0.458333333333333","rgba(125,138,174,1)"],["0.5","rgba(125,147,166,1)"],["0.541666666666667","rgba(125,156,158,1)"],["0.583333333333333","rgba(124,165,150,1)"],["0.625","rgba(123,174,141,1)"],["0.666666666666667","rgba(120,183,133,1)"],["0.708333333333333","rgba(116,192,124,1)"],["0.75","rgba(111,201,114,1)"],["0.791666666666667","rgba(105,210,104,1)"],["0.833333333333333","rgba(97,219,92,1)"],["0.875","rgba(87,228,79,1)"],["0.916666666666667","rgba(73,237,64,1)"],["0.958333333333333","rgba(52,246,44,1)"],["1","rgba(0,255,0,1)"]],"showscale":false,"color":[1.7984806959087485,-0.49969634350375841,2.4353531824483436,0.63405198918775807,-1.522213900615502,1.0248389586175237,2.5189307633519533,2.4190755272227609,2.0661030045451168,1.9556811314634255,2.5768103293901206,1.9886535023326743,2.0977219480164111]}},"type":"scatter","xaxis":"x","yaxis":"y","frame":null},{"x":[-1.522213900615502,2.5768103293901206],"y":[1.016346109984575,2.5919454836768852],"type":"scatter","mode":"markers","opacity":0,"hoverinfo":"none","showlegend":false,"marker":{"colorbar":{"title":"log2rr","ticklen":2,"len":0.5,"lenmode":"fraction","y":1,"yanchor":"top"},"cmin":-1.522213900615502,"cmax":2.5768103293901206,"colorscale":[["0","rgba(0,0,255,1)"],["0.0416666666666667","rgba(49,29,248,1)"],["0.0833333333333334","rgba(69,45,241,1)"],["0.125","rgba(83,58,233,1)"],["0.166666666666667","rgba(93,70,226,1)"],["0.208333333333333","rgba(102,81,219,1)"],["0.25","rgba(108,91,211,1)"],["0.291666666666667","rgba(113,101,204,1)"],["0.333333333333333","rgba(118,110,197,1)"],["0.375","rgba(121,120,189,1)"],["0.416666666666667","rgba(123,129,182,1)"],["0.458333333333333","rgba(125,138,174,1)"],["0.5","rgba(125,147,166,1)"],["0.541666666666667","rgba(125,156,158,1)"],["0.583333333333333","rgba(124,165,150,1)"],["0.625","rgba(123,174,141,1)"],["0.666666666666667","rgba(120,183,133,1)"],["0.708333333333333","rgba(116,192,124,1)"],["0.75","rgba(111,201,114,1)"],["0.791666666666667","rgba(105,210,104,1)"],["0.833333333333333","rgba(97,219,92,1)"],["0.875","rgba(87,228,79,1)"],["0.916666666666667","rgba(73,237,64,1)"],["0.958333333333333","rgba(52,246,44,1)"],["1","rgba(0,255,0,1)"]],"showscale":true,"color":[-1.522213900615502,2.5768103293901206],"line":{"color":"rgba(255,127,14,1)"}},"xaxis":"x","yaxis":"y","frame":null}],"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.20000000000000001,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script>
</div>
<div id="tendril-plot" class="section level2">
<h2>Tendril Plot</h2>
<p>The Tendril plot concept is illustrated using the preferred term of
Back Pain. Events on placebo tilt the tendril to the right and events on
active tilt the tendril to the left. In this illustrative plot, events
are colored by treatment arm; yellow and brown circles for placebo and
active arm, respectively. The distance between points are proportional
to time between events.</p>
<p><img src="./02_Plots/Visualization/AEs/AE_Tendril_Intro.png" /></p>
<p><a href="https://steve-mallett.shinyapps.io/TendrilPlot/">Tendril
Plot Shiny App</a></p>
<p>This tendril plot provides a visual comparison of System Organ Class
Adverse Events (AEs) between a placebo group and an intervention group
in a clinical study. Each tendril represents a different category of
AEs, such as gastrointestinal or neurological, differentiated by color.
The plot’s horizontal axis divides the two study groups, while the
vertical axis indicates the progression of the study, though specific
time units are not provided.</p>
<p>In the plot, the length and direction of each tendril illustrate the
incidence and progression of AEs in each category relative to the
treatment group. For example, lines extending significantly toward the
intervention side indicate a higher occurrence of AEs in that group
compared to placebo. This visual tool is effective for quickly assessing
the safety profile and identifying the most prevalent adverse events in
each treatment group during the study.</p>
<p><img src="02_Plots/Visualization/AEs/AE_Tendril.png" /></p>
<pre class="r"><code># packages
pacman::p_load(tidyverse, rio)
pacman::p_load(lubridate)
pacman::p_load(labelled)
pacman::p_load(Tendril)
pacman::p_load(ggtext)
pacman::p_load(colorspace)

# import
ae &lt;- read_csv(&quot;./01_Datasets/2020-08-12_ae_example_dataset.csv&quot;) %&gt;% 
  mutate(rando_date = ymd(rando_date),
         aestdat = ymd(aestdat),
         aeeddat = ymd(aeeddat)) %&gt;% 
  mutate(day = as.numeric(aestdat - rando_date)) %&gt;% 
  as.data.frame()

# Fixed mistake in subject 2011
ae[ae$usubjid == &quot;2011&quot;, &quot;arm&quot;] &lt;- &quot;Intervention&quot;

# add labels
var_label(ae) &lt;- list(
  usubjid = &quot;unique subject identifier&quot;,
  arm = &quot;treatment assignment name&quot;,
  armn = &quot;treatment assignment numeric (0: placebo; 1:intervention)&quot;,
  rando_date = &quot;date of randomisation (yyyymmdd)&quot;,
  repeatnum = &quot;unique event identifier within usubjid&quot;,
  aept = &quot;adverse event code at preferred term/lower level&quot;,
  aebodsys = &quot;adverse event code at body system/higher level&quot;,
  aesev = &quot;adverse event severity grade (mild, moderate, severe)&quot;,
  aesevn = &quot;adverse event severity grade number (1: mild, 2: moderate, 3: severe)&quot;,
  aeser = &quot;serious adverse event (no, yes)&quot;,
  aesern = &quot;serious adverse event (0: no, 1: yes)&quot;,
  aestdat = &quot;adverse event start date (yyyymmdd)&quot;,
  aeeddat = &quot;adverse event end date (yyyymmdd)&quot;,
  dur = &quot;adverse event duration (days)&quot;)
 

# Tendril
subj &lt;- ae %&gt;%
  dplyr::count(usubjid, arm) %&gt;% 
  #add_row(usubjid = 3000, arm = &quot;Intervention&quot;, n = 0) %&gt;% 
  #add_row(usubjid = 3001, arm = &quot;Placebo&quot;,      n = 0) %&gt;%
  select(-n) %&gt;% 
  as.data.frame()

pt &lt;- Tendril(mydata = ae,
              rotations = rep(3, nrow(ae)),
              AEfreqThreshold = 5,
              Tag = &quot;Comment&quot;,
              Treatments = c(&quot;Intervention&quot;, &quot;Placebo&quot;),
              Unique.Subject.Identifier = &quot;usubjid&quot;,
              Terms = &quot;aebodsys&quot;,
              #Terms = &quot;aept&quot;,
              Treat = &quot;arm&quot;,
              StartDay = &quot;day&quot;,
              # SubjList = subj,
              # SubjList.subject = &quot;usubjid&quot;,
              # SubjList.treatment = &quot;arm&quot;,
              # filter_double_events = TRUE
)

# working with terms 
Terms &lt;- pt$data %&gt;% 
  dplyr::group_by(Terms) %&gt;% 
  dplyr::summarise(n = n(), x = x[n]) %&gt;% 
  dplyr::ungroup() %&gt;% 
  arrange(x) %&gt;% 
  mutate(text = str_glue(&quot;{Terms} (n={n})&quot;)) 

# Reorder guides
pt$data$Terms &lt;- fct_relevel(pt$data$Terms,
                             Terms %&gt;% 
                               pull(Terms) %&gt;% 
                               as.vector()
)

levels(pt$data$Terms) &lt;- Terms %&gt;% pull(text) %&gt;% as.vector()

# plot Results
plot(pt) +
  geom_point(alpha = 0.25) +
  geom_path(alpha = 0.25) +
  geom_vline(xintercept = 0, color = &#39;gray50&#39;, linetype = &quot;dashed&quot;) +
  geom_hline(yintercept = 0, color = &#39;gray50&#39;, linetype = &quot;dashed&quot;) +
  #scale_color_brewer(type = &quot;qual&quot;, palette = &quot;Set1&quot;) +
  scale_color_discrete_qualitative(palette = &quot;Dark3&quot;)+
  scale_x_continuous(limits = c(-100, 200)) +
  labs(title = &quot;**Tendril Plot** of System Organ Class Adverse Events (AE) having at least 5 incidences&quot;,
       # caption =&quot;The Tendril Plot: a novel visual summary of the incidence, significance and temporal aspects of AE in clinical trials (JAMIA 2018; 25(8): 1069-1073)&quot;
       caption = 
       &quot;Each MedDRA adverse event code at body system/higher level is
       represented by a line (tendril) and each point is an event. Since time runs
       along each tendril, it is the shape that carries the important information,
       rather than the x and y coordinates. An event on the Intervention treatment
       arm will tilt tendril direction to the *right*, and an event on the placebo arm will
       tilt tendril direction to the *left*.
       &lt;br&gt;
       *The Tendril Plot: a novel visual summary of the incidence, significance and temporal aspects of AE in clinical trials (JAMIA 2018; 25(8): 1069-1073)*&quot;
       ) +
  guides(color = guide_legend(title = &quot;AE at Body System&quot;)) +
  theme(aspect.ratio = 0.70,
        plot.title = element_markdown(),
        plot.caption = element_textbox_simple(
          size = 8,
          lineheight = 1,
          hjust = 0, vjust = 1,
          padding = margin(1, 1, 1, 1),
          margin = margin(1, 1, 1, 1)
        ),
        plot.caption.position = &quot;plot&quot;,
        legend.position       = c(0.99,0.92),
        legend.justification  = c(1,1),
        legend.background     = element_rect(fill  = &#39;gray90&#39;),
        legend.key            = element_rect(fill  = &#39;gray90&#39;))</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-10-1.png" width="672" /></p>
<pre class="r"><code># ggsave(&quot;./tendril_plot.png&quot;,
#        width = 7.5, height = 6, units = &quot;in&quot;)</code></pre>
</div>
<div id="double-dot-plot" class="section level2">
<h2>Double Dot Plot</h2>
<p><img src="02_Plots/Visualization/ForestPlot/DoubleDot.png" /></p>
<pre class="r"><code># Simulating data
set.seed(123)
data &lt;- data.frame(
  Category = c(&quot;Social circumstances&quot;, &quot;Immune system disorders&quot;, &quot;Endocrine disorders&quot;,
               &quot;Neoplasms benign, malignant and unspecified (incl cysts and polyps)&quot;, 
               &quot;Ear and labyrinth disorders&quot;, &quot;General disorders and administration site conditions&quot;,
               &quot;Injury, poisoning and procedural complications&quot;, &quot;Investigations&quot;, &quot;Nervous system disorders&quot;,
               &quot;Metabolism and nutrition disorders&quot;, &quot;Vascular disorders&quot;, &quot;Renal and urinary disorders&quot;,
               &quot;Infections and infestations&quot;, &quot;Musculoskeletal and connective tissue disorders&quot;,
               &quot;Skin and subcutaneous tissue disorders&quot;, &quot;Pregnancy, puerperium and perinatal conditions&quot;,
               &quot;Congenital, familial and genetic disorders&quot;, &quot;Gastrointestinal disorders&quot;, &quot;Eye disorders&quot;,
               &quot;Respiratory, thoracic and mediastinal disorders&quot;, &quot;Reproductive system and breast disorders&quot;,
               &quot;Cardiac disorders&quot;, &quot;Hepatobiliary disorders&quot;, &quot;Psychiatric disorders&quot;, &quot;Surgical and medical procedures&quot;),
  Proportion = runif(25, 0.01, 0.04),
  Proportion2 = runif(25, 0.01, 0.04),
  RelativeRisk = runif(25, 0.5, 2),
  LowerCI = runif(25, 0.1, 1.5),
  UpperCI = runif(25, 1.5, 3),
  Pvalue = runif(25, 0.001, 1)
)

data$Significant &lt;- ifelse(data$Pvalue &lt; 0.05, &quot;red&quot;, &quot;black&quot;)


double_dot_plot &lt;- ggplot(data, aes(x = Category)) +
  geom_point(aes(y = Proportion), color = &quot;blue&quot;, size = 3) +
  geom_point(aes(y = Proportion2), color = &quot;red&quot;, size = 3) +
  coord_flip() +
  scale_y_continuous(labels = scales::percent_format(), breaks = seq(0, 0.04, by = 0.01)) +
  labs(y = &quot;Proportion&quot;, x = NULL, title = &quot;Double Dot Plot&quot;) +
  theme_minimal()

risk_plot &lt;- ggplot(data, aes(x = Category, y = RelativeRisk)) +
  geom_pointrange(aes(ymin = LowerCI, ymax = UpperCI), size = 0.5) +
  geom_text(aes(label = sprintf(&quot;%.3f&quot;, Pvalue), color = Significant), hjust = 1.5, size = 3) +
  coord_flip() +
  scale_y_log10(breaks = c(0.1, 0.5, 1, 2, 10), labels = scales::trans_format(&quot;log10&quot;, scales::math_format(10^.x))) +
  labs(y = &quot;Relative Risk with 95% CI&quot;, x = NULL, title = &quot;Relative Risk Plot&quot;) +
  theme_minimal() +
  theme(axis.text.y = element_blank(), axis.ticks.y = element_blank(), axis.title.y = element_blank()) +
  scale_color_identity()

grid.arrange(double_dot_plot, risk_plot, ncol = 2)</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-11-1.png" width="672" /></p>
</div>
<div id="triangles-plot" class="section level2">
<h2>Triangles Plot</h2>
<p>This visualisation has been submitted as an html file and can be
found <a
href="https://vis-sig.github.io/blog/posts/2020-10-17-wonderful-wednesdays-september-2020/">here</a>.</p>
<p><img src="./02_Plots/Visualization/AEs/Triangles.png" /></p>
<p>The above visualization is based on clinical trial data for an active
treatment for eczema compared to placebo in adolescents that are
unresponsive to standard care.</p>
<p>An analysis revealed that more adverse events were recorded for
subjects that were assigned to an intervention treatment arm, compared
to those assigned to a placebo.</p>
</div>
<div id="pie-chart" class="section level2">
<h2>Pie Chart</h2>
<p>This visualisation has been submitted as an html file and can be
found <a
href="https://vis-sig.github.io/blog/posts/2020-10-17-wonderful-wednesdays-september-2020/">here</a>.</p>
<p><img src="./02_Plots/Visualization/AEs/Pie.png" /></p>
</div>
<div id="boxplot-for-duration-aes" class="section level2">
<h2>Boxplot for Duration AEs</h2>
<p><img src="./02_Plots/Visualization/AEs/BoxplotDuration.png" /></p>
<p>Subjects assigned to placebo treatment arm that reported an adverse
event had their event treated in a duration of 6 days, on average.
Participants assigned to interevention treatment, on average, saw the
end of their adverse event in 8 days.</p>
</div>
<div id="adepro-app-development-of-aes-over-time"
class="section level2">
<h2>AdEPro App: development of AEs over time</h2>
<p>This is definitely more than just a visualisation - it’s a tool. You
can upload your data and all AEs are represented in the middle pane.
Each patient is represented by a circle / pie chart. You can kick it off
by pushing the go button and the app will show you the development of
AEs over time. Each AE is represented by a “slice of the pie” and the
color as well as the location of it will tell you which AE is showing.
If an AE disappears, it will still be shown as an “empty slice”. The
size of the slice represents the severity. You have several different
options you can work with, like changing which AEs will be shown (color
coded), stop at a specific point in time, etc. You can even switch to a
barplot representation instead of pie charts.</p>
<p>This is a fully developed app and thus, it is very useful and
innovative. Its interactivity brings additional benefits to the user.
Furthermore, this is available as an R package called “AdEPro”.</p>
<pre class="r"><code># library(adepro) 

#Run this code to put the variables in the dataset provided into the correct format
AE &lt;- read.csv(&quot;./01_Datasets/2020-08-12_ae_example_dataset.csv&quot;)%&gt;%
  mutate(TRTSDT=ymd(rando_date)) %&gt;%
  mutate(SUBJIDN = usubjid) %&gt;%
  mutate(AEDECOD = aept) %&gt;%
  mutate(TRT01A = arm) %&gt;%
  mutate(TRT01A = if_else(TRT01A==&quot;Intervention&quot;,&quot;Experimental&quot;,&quot;Control&quot;)) %&gt;%
  mutate(LVDT = 365) %&gt;%
  mutate(DTHDT = &quot;NA&quot;) %&gt;%
  mutate(SAFFN = 1) %&gt;%
  mutate(AETRTEMN = 1) %&gt;%
  mutate(AESERN = aesern) %&gt;%
  mutate(AERELN = 1) %&gt;%
  mutate(AE_Start = ymd(aestdat)) %&gt;%
  mutate(AESTDY = AE_Start - TRTSDT + 1)%&gt;%
  mutate(AEENDY = AESTDY + dur + 1) %&gt;%
  mutate(AESEVN = aesevn) %&gt;%
  mutate(TRTSDT=0) %&gt;%
  mutate(AGE=&quot;NA&quot;) %&gt;%
  mutate(SEX=&quot;NA&quot;) %&gt;%
  mutate(REGION=&quot;NA&quot;) %&gt;%
  select(c(SUBJIDN,AEDECOD,AESTDY, AEENDY,AESEVN,AETRTEMN,AESERN,AERELN, TRT01A, TRTSDT, LVDT, DTHDT,AGE, SEX, REGION, SAFFN))

#write this back to CSV
write.csv(AE,&quot;./01_Datasets/adepro_app_AE.csv&quot;,row.names=FALSE)

#Run the following line to run the app.
#CSV must be loaded into the app
# launch_adepro()</code></pre>
</div>
</div>
<div id="disease-incidence" class="section level1">
<h1>Disease Incidence</h1>
<div id="heatmap" class="section level2">
<h2>Heatmap</h2>
<p>The purpose of creating this visualization is to explore and
illustrate patterns in disease incidence across the United States from
1928 to 2000, focusing on diseases like measles, polio, and rubella. The
visualization aims to answer key questions: How has the incidence rate
of each disease changed over time? How does incidence vary across
different states? And, importantly, what impact did vaccination have on
disease incidence rates?</p>
<pre class="r"><code>df &lt;- read.csv(&quot;./01_Datasets/US_state_epi_vaccines.csv&quot;)

# Records of the year for which each vaccine was introduced
vac_dat &lt;- data.frame(disease = c(&quot;MEASLES&quot;, &quot;POLIO&quot;, &quot;RUBELLA&quot;), 
                      Z = c(1963, 1955, 1969))

df %&gt;%
  na.omit() %&gt;%
  ggplot() +
  geom_tile(aes(x = year, y = state, fill = incidence)) +
  scale_fill_gradient2(trans = &quot;log10&quot;, high = &quot;red&quot;, low = &quot;blue&quot;, 
                       mid = &quot;white&quot;, midpoint = 0, na.value = &quot;white&quot;) +
  scale_x_continuous(expand = c(0.02, 0.02)) +
  geom_vline(data = vac_dat, aes(xintercept = Z), linewidth = 1.5, color = &quot;darkred&quot;) +
  facet_wrap(~disease, scales = &quot;free&quot;) +
  dark_theme_minimal() +
  theme(axis.text.y =  element_text(size = 5), 
        plot.title = element_text(hjust = 0.5, size = 16)) +
  labs(y = &quot;State&quot;, fill = &quot;Log \nIncidence&quot;, x = &quot;Year&quot;, 
       title = &quot;Visulaizing Effect of Vaccines&quot;,
       caption = &quot;Dark Red Line Indicates Introduction of Vaccine&quot;)</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-13-1.png" width="672" /></p>
<pre class="r"><code>inc &lt;- read.csv(&quot;./01_Datasets/US_state_epi_vaccines.csv&quot;)

measles &lt;- inc %&gt;%
  filter(disease == &quot;MEASLES&quot;) %&gt;%
  mutate(inc_cat = cut(incidence, c(0, 200, 400, 600, 800, 1000, 1200, Inf))) %&gt;%
  mutate(inc_fac = factor(inc_cat)) 

ggplot(data=measles) +
  geom_tile(aes(x=year, y=state, fill=inc_fac), color=&quot;gray&quot;) +
  scale_x_continuous(&quot;Year&quot;, breaks=seq(1930, 2010, by=10), limits = c(1928, 2000)) +
  scale_y_discrete(&quot;State&quot;, limits=rev) +
  geom_vline(xintercept = 1963, size = 1, color = &quot;#d7191c&quot;) +
  scale_fill_brewer(&quot;Incidence\nPer\n100,0000\nPopulation&quot;, 
                    labels=c(&quot;0-&lt;200&quot;, &quot;200-&lt;400&quot;, &quot;400-&lt;600&quot;, &quot;600-&lt;800&quot;, &quot;800-&lt;1000&quot;, &quot;1000-&lt;1200&quot;, &quot;&gt;=1200&quot;),
                    na.value = &#39;white&#39;,
                    na.translate = F) +
  labs (title =&quot;Incidence of measles in US states declines after &lt;b style=&#39;color:#d7191c;&#39;&gt;vaccine approval&lt;/b&gt;&quot;)+
  theme_minimal() +
  theme(legend.title.align = 0.5,
        axis.text.x = element_text(size = 12, color = &quot;#525252&quot;),
        axis.text.y = element_text(size = 8, color = &quot;#525252&quot;),
        axis.line.y = element_blank(),
        axis.ticks.y = element_blank(),
        panel.grid.major = element_blank(),
        plot.title = element_markdown())</code></pre>
<p><img src="08-Clinical-Adverse-Event_files/figure-html/unnamed-chunk-14-1.png" width="672" /></p>
</div>
</div>
<div id="reference" class="section level1">
<h1>Reference</h1>
<ul>
<li><a
href="https://www.linkedin.com/pulse/most-frequent-ae-relative-risk-using-r-jagadish-katam/?trackingId=GllB04d3RAe%2BIPwtx1czFg%3D%3D">Most
Frequent AE by Relative Risk/Forest Plot using</a></li>
<li><a href="https://www.lexjansen.com/phuse/2018/dv/DV11.pdf">Adverse
Event Data – gRaphically</a></li>
<li>SIG (2024, Feb. 8). VIS-SIG Blog: Wonderful Wednesdays February
2024. Retrieved from <a
href="https://graphicsprinciples.github.io/posts/2024-09-01-wonderful-wednesdays-february-2024/"
class="uri">https://graphicsprinciples.github.io/posts/2024-09-01-wonderful-wednesdays-february-2024/</a></li>
<li>SIG (2023, July 12). VIS-SIG Blog: Wonderful Wednesdays July 2023.
Retrieved from <a
href="https://graphicsprinciples.github.io/posts/2023-12-17-wonderful-wednesdays-july-2023/"
class="uri">https://graphicsprinciples.github.io/posts/2023-12-17-wonderful-wednesdays-july-2023/</a></li>
<li>SIG (2022, Dec. 14). VIS-SIG Blog: Wonderful Wednesdays December
2022. Retrieved from <a
href="https://graphicsprinciples.github.io/posts/2023-04-16-wonderful-wednesdays-december-2022/"
class="uri">https://graphicsprinciples.github.io/posts/2023-04-16-wonderful-wednesdays-december-2022/</a></li>
<li><a
href="https://jagadishkatam.github.io/SankeySlides/sankey.html#/title-slide">Comparative
Analysis of Sankey Diagram Generation Using Different R Packages
{networkD3}, {plotly}, {ggalluvial} for TEAE Data Visualisation</a></li>
</ul>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->
<script>
$(document).ready(function () {
  window.initializeCodeFolding("hide" === "show");
});
</script>

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
